Ruxolitinib treatment for acute gastrointestinal graft-versus-host disease caused by donor-derived CD19-Chimeric antigen receptor T-Cell infusion in a patient with B-ALL relapsed after Allo-HSCT

Detalles Bibliográficos
Autores principales: Yang, Yingying, Hu, Yongxian, Huang, He
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japanese Society for Regenerative Medicine 2019
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6646647/
https://www.ncbi.nlm.nih.gov/pubmed/31367654
http://dx.doi.org/10.1016/j.reth.2019.06.006
_version_ 1783437582725545984
author Yang, Yingying
Hu, Yongxian
Huang, He
author_facet Yang, Yingying
Hu, Yongxian
Huang, He
author_sort Yang, Yingying
collection PubMed
description
format Online
Article
Text
id pubmed-6646647
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Japanese Society for Regenerative Medicine
record_format MEDLINE/PubMed
spelling pubmed-66466472019-07-31 Ruxolitinib treatment for acute gastrointestinal graft-versus-host disease caused by donor-derived CD19-Chimeric antigen receptor T-Cell infusion in a patient with B-ALL relapsed after Allo-HSCT Yang, Yingying Hu, Yongxian Huang, He Regen Ther Letter to the Editor Japanese Society for Regenerative Medicine 2019-07-15 /pmc/articles/PMC6646647/ /pubmed/31367654 http://dx.doi.org/10.1016/j.reth.2019.06.006 Text en © 2019 The Japanese Society for Regenerative Medicine. Production and hosting by Elsevier B.V. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Letter to the Editor
Yang, Yingying
Hu, Yongxian
Huang, He
Ruxolitinib treatment for acute gastrointestinal graft-versus-host disease caused by donor-derived CD19-Chimeric antigen receptor T-Cell infusion in a patient with B-ALL relapsed after Allo-HSCT
title Ruxolitinib treatment for acute gastrointestinal graft-versus-host disease caused by donor-derived CD19-Chimeric antigen receptor T-Cell infusion in a patient with B-ALL relapsed after Allo-HSCT
title_full Ruxolitinib treatment for acute gastrointestinal graft-versus-host disease caused by donor-derived CD19-Chimeric antigen receptor T-Cell infusion in a patient with B-ALL relapsed after Allo-HSCT
title_fullStr Ruxolitinib treatment for acute gastrointestinal graft-versus-host disease caused by donor-derived CD19-Chimeric antigen receptor T-Cell infusion in a patient with B-ALL relapsed after Allo-HSCT
title_full_unstemmed Ruxolitinib treatment for acute gastrointestinal graft-versus-host disease caused by donor-derived CD19-Chimeric antigen receptor T-Cell infusion in a patient with B-ALL relapsed after Allo-HSCT
title_short Ruxolitinib treatment for acute gastrointestinal graft-versus-host disease caused by donor-derived CD19-Chimeric antigen receptor T-Cell infusion in a patient with B-ALL relapsed after Allo-HSCT
title_sort ruxolitinib treatment for acute gastrointestinal graft-versus-host disease caused by donor-derived cd19-chimeric antigen receptor t-cell infusion in a patient with b-all relapsed after allo-hsct
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6646647/
https://www.ncbi.nlm.nih.gov/pubmed/31367654
http://dx.doi.org/10.1016/j.reth.2019.06.006
work_keys_str_mv AT yangyingying ruxolitinibtreatmentforacutegastrointestinalgraftversushostdiseasecausedbydonorderivedcd19chimericantigenreceptortcellinfusioninapatientwithballrelapsedafterallohsct
AT huyongxian ruxolitinibtreatmentforacutegastrointestinalgraftversushostdiseasecausedbydonorderivedcd19chimericantigenreceptortcellinfusioninapatientwithballrelapsedafterallohsct
AT huanghe ruxolitinibtreatmentforacutegastrointestinalgraftversushostdiseasecausedbydonorderivedcd19chimericantigenreceptortcellinfusioninapatientwithballrelapsedafterallohsct

Ejemplares similares